Alexander Gambon, Chief Brand Officer at ELONGATE, and Michael Hund, CEO of EB Research Partnership, were featured in a segment on the Lifetime TV cable network. They discussed Epidermolysis Bullosa, or EB for short, and how EB Research Partnership leads the charge to develop a cure for the rare and often debilitating disease along with the support of Elongate.
Earlier this year, the two organizations partnered together to form the #CryptoForCures fund, with Elongate donating over $200,000 to the fund in under six months. Elongate will also be the title sponsor of EBRPs Venture Into Cures fundraiser in November, including an extensive celebrity lineup.